In 2005, the 27 member states of the European Union agreed a drug strategy that runs from 2005 to 2012, with a mid-term review of progress in 2008. This advocacy note gives the IDPC perspective on this progress review, and makes recommendations for the action plan for the remaining 4 years of the strategy. As this revised action plan is now being finalised by member states, NGOs wishing to influence this process should urgently contact the relevant officials in their country to promote these recommendations.